Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

The Power of Storytelling in Health: Friend or Foe?

With traditional media moving online, and the era of social media driving stories through the ethernet, never has a ‘story’ been more impactful.

- PMLiVE

Kite wins FDA approval for blood cancer drug Yescarta

Becomes the first CAR-T therapy approved in the US for B-cell lymphoma

- PMLiVE

Tools for the digital world

The next step for the pharma industry

Gilead Sciences promotes Dr Alessandro Riva to EVP, oncology therapeutics

He's been with the firm since January, when he joined from Novartis

Scancell appoints Dr Cliff Holloway as CEO

He joins the immunotherapy firm from Benitec Biopharma

- PMLiVE

Onyx Health wins two new accounts

Newcells Biotech and HeartScan appoint marketing comms agency

- PMLiVE

Health Unlimited strengthens offering with London move

Agency relocates to Soho to boost output and diversify talent pool

- PMLiVE

IPA reveals Best of Health show 2017 shortlist

20 agencies are in with the chance of winning an award

Eli Lilly HQ

Lilly expands its immuno-oncology work with $1.8bn CureVac deal

Will work with the German firm to develop ‘next generation’ cancer vaccines

- PMLiVE

MSD touts Keytruda first-line promise in NSCLC

Says patients on the drug more than doubled median OS compared to chemo

AstraZeneca AZ

AZ and MSD win FDA priority review for Lynparza in breast cancer

Could become the first PARP inhibitor to be approved in the US for the disease

- PMLiVE

Anish Mehta appointed CEO of new women’s health business

Will head up the former Teva portoflio CVC Capital Partners recently acquired

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links